Price
Target price
€8.80
€8.80
1.730%
0.15
1.730%
-
27.09.24 / Stuttgart Stock Exchange
WKN: A2DG49 / Name: KalVista / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Carbylan Therapeutics Inc Stock
Carbylan Therapeutics Inc gained 1.730% today.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Carbylan Therapeutics Inc stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Carbylan Therapeutics Inc in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carbylan Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Carbylan Therapeutics Inc | 1.730% | -7.368% | -24.138% | -3.297% | -19.266% | -39.726% | -17.510% |
| Syros Pharmaceuticals Inc. | 2.860% | 2.874% | 18.543% | -41.118% | -72.879% | -95.214% | - |
| Clinuvel Pharmaceuticals | 1.330% | -2.581% | -7.066% | -4.615% | -11.374% | -65.583% | -44.395% |
| Pharma Mar S.A. | 3.350% | 1.560% | 18.846% | 52.179% | 13.632% | -34.449% | 119.759% |